Patient recruitment at the speed of science

Learn how Sermonix Pharmaceuticals partnered with Tempus and its TIME network of clinical sites to accelerate patient recruitment for a phase 2 study.
Authors Sibel Blau, MD
President and CEO, Quality Cancer Care Alliance Network
Medical Director, Northwest Medical Specialties

Matthew Cooney, MD
Vice President, Therapeutic Development, Tempus

Read the full article here

Related Content

View more